000 | 01656pam a22004214a 4500 | ||
---|---|---|---|
001 | B000000793 | ||
003 | DNLM | ||
005 | 20161018151804.0 | ||
006 | m d | ||
008 | 010718s2002 paua sb 001 0 eng | ||
010 | _a 2001038463 | ||
020 | _a9780781728379 | ||
020 | _a0781728371 | ||
035 | _a101123129(DNLM) | ||
040 |
_aDNLM _cDNLM _dDNLM |
||
049 | _aAlfaisal Main Library | ||
050 | 0 | 0 |
_aRM315 _b.N4825 2002 |
060 | 0 | 0 | _a2002 E-787 |
060 | 1 | 0 |
_aQV 77 _bN4968 2002 |
245 | 0 | 0 |
_aNeuropsychopharmacology _h[electronic resource] : _bthe fifth generation of progress : an official publication of the American College of Neuropsychopharmacology / _ceditors, Kenneth L. Davis ... [et al.]. |
260 |
_aPhiladelphia : _bLippincott Williams & Wilkins, _cc2002. |
||
300 |
_axxi, 2010 p. : _bill. |
||
504 | _aIncludes bibliographical references and index. | ||
533 |
_aElectronic reproduction. _bNew York, N.Y. : _cOvid Technologies, Inc. _nAvailable via World Wide Web. |
||
650 | 1 | 2 |
_aPsychopharmacology _xmethods |
650 | 2 | 2 |
_aDiagnostic Imaging _xmethods |
650 | 2 | 2 | _aDrug Evaluation |
650 | 2 | 2 |
_aNeurotransmitter Agents _xphysiology |
650 | 0 | _aNeuropsychopharmacology. | |
650 | 0 | _aNeurobehavioral disorders. | |
655 | 7 |
_aElectronic books. _2local |
|
700 | 1 |
_aDavis, Kenneth L., _d1947- |
|
710 | 2 | _aOvid eBooks. | |
710 | 2 | _aAmerican College of Neuropsychopharmacology. | |
710 | 2 | _aOvid Technologies, Inc. | |
856 | 4 | 0 | _uhttp://ezproxy.alfaisal.edu/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=booktext&NEWS=N&DF=bookdb&AN=00149849/5th_Edition/3&XPATH=/PG(0) |
942 |
_2lcc _cEBOOKS |
||
999 |
_c420749 _d420749 |